acarbose vs tirzepatide
Side-by-side comparison of acarbose and tirzepatide Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
Precose
Mounjaro, Zepbound
Acarbose is a medicine that helps lower blood sugar levels in people with type 2 diabetes. It works best when used with diet and exercise.
Zepbound is a medicine that can help adults with obesity or overweight lose weight and keep it off. It can also treat moderate to severe sleep apnea in adults with obesity.
Acarbose is used to help control blood sugar in adults with type 2 diabetes. You should use it along with a healthy diet and regular exercise. This medicine helps to keep your blood sugar from getting too high after you eat.
Zepbound helps adults with obesity or who are overweight to lose weight. It is used along with a reduced-calorie diet and exercise. It can also help people keep the weight off long-term. Zepbound can also treat moderate to severe obstructive sleep apnea (OSA) in adults with obesity.
Acarbose slows down the digestion of carbohydrates (sugars and starches) in your body. It does this by blocking certain enzymes in your small intestine that break down carbs. This helps to prevent a sharp rise in blood sugar after meals.
Zepbound works by activating two receptors in your body: GIP and GLP-1. These receptors help control your blood sugar and appetite. By activating these receptors, Zepbound can help you feel fuller, eat less, and lose weight.
- • Gas
- • Diarrhea
- • Abdominal pain
- • Nausea
- • Diarrhea
- • Vomiting
- • Constipation
- • Abdominal pain
- Low blood sugar 269
- Feeling sick to your stomach 203
- High blood sugar 200
- Feeling lightheaded 160
- Loose, watery stools 147
- Wrong dose given 25,919
- Pain where you injected the medicine 12,325
- Feeling sick to your stomach 12,028
- An extra dose was given 8,027
- Using the medicine for something it's not approved for 7,726
You should not take acarbose if you have diabetic ketoacidosis or cirrhosis. Also, do not take it if you have inflammatory bowel disease, colon ulcers, or any bowel obstruction. This medicine can cause liver problems in some people. Tell your doctor right away if you develop symptoms like yellowing of the skin or eyes.
Zepbound may cause thyroid C-cell tumors in rats. It is not known if Zepbound causes thyroid tumors in humans. You should not take Zepbound if you or your family have a history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Tell your doctor if you have a lump in your neck, trouble swallowing, trouble breathing, or a hoarse voice that doesn't go away.
Talk to your doctor if you are pregnant or plan to become pregnant. It is not known if acarbose will harm your unborn baby. Talk to your doctor if you are breastfeeding or plan to breastfeed. It is not known if acarbose passes into breast milk.
Zepbound may harm your unborn baby. Weight loss is not recommended during pregnancy. If you become pregnant, stop taking Zepbound.
Also Compare — Nearby Drugs
Compare acarbose with
How to Read This acarbose vs tirzepatide Comparison
acarbose is classified in the Alpha-Glucosidase Inhibitor drug class, while tirzepatide sits within the Dual GIP/GLP-1 Receptor Agonist class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, acarbose has 979 submissions while tirzepatide has 66,025. Those figures reflect cumulative reporting volume — not per-patient risk — so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between acarbose and tirzepatide — always consult your physician or pharmacist first.
Important: This comparison is for informational purposes only. Drug effects vary between individuals. Always consult your doctor or pharmacist for personalized medical advice.